Deter FS 250

Primær information

  • Handelsnavn:
  • Deter FS 250 Flydende bejdse
  • Lægemiddelform:
  • Flydende bejdse
  • Sammensætning:
  • 250 g/l clothianidin
  • Brugt til:
  • Planter
  • Medicin typen:
  • agrokemiske

Dokumenter

Lokation

  • Fås i:
  • Deter FS 250 Flydende bejdse
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • SEGES Landbrug & Fødevarer
  • Autorisation status:
  • Udgået
  • Autorisationsnummer:
  • Ingen afstandskrav til vandmiljø grundet industriel anvendelse.
  • Sidste ændring:
  • 23-07-2018

Indlægsseddel

ADVARSEL

Brugsanvisningen skal følges for ikke at bringe

menneskers sundhed og miljøet i fare (EUH401).

Kan forårsage allergisk hudreaktion (H317).

Meget giftig med langvarige virkninger for vandle-

vende organismer (H410).

Bær beskyttelseshandsker (P280).

Undgå udledning til miljøet (P273).

Udslip opsamles (P391).

Vær opmærksom på, at Arbejdstilsynet har regler for

arbejde med og udsættelse for plantebeskyttelses-

midler. Læs nærmere i det eventuelt lovpligtige sik-

kerhedsdatablad.

Anvendelse, herunder såning af kornet, og opbeva-

ring sker alene efter dispensation fra godkendelses-

ordningen for pesticider. Dispensation til anvendelse

gælder i perioden: 29. juli – 31. oktober 2015.Tilla-

delse til opbevaring bortfalder den 31. oktober 2015.

Overtrædelse af nedenstående særligt fremhævede

forskrifter kan medføre straf:

Må kun anvendes til indendørs bejdsning af vin-

terhvede og vinterbyg i lukkede industrielle anlæg.

Må ikke anvendes mod andre skadevoldere og ikke

i højere doseringer end de i brugsanvisningen nævnte.

Undgå forurening af vandmiljøet med produktet eller med beholdere, der har inde-

holdt produktet (SP

1

).

Må ikke tømmes i kloakafløb.

Det bejdsede korn skal umiddelbart efter bejdsningen emballeres i en beholder/

emballage og plomberes.

Det bejdsede korn er bejdset med Deter FS 250 som indeholder clothianidin.

Det bejdsede korn må kun sås i risikoområder for virussygdommen havrerødsot,

og hvis der sås tidligt.

Der skal anvendes passende radsåningsudstyr, som sikrer en god nedfældning i

jorden, minimalt spild under anvendelsen og minimal frigivelse af støv.

Det bejdsede korn er farligt og må ikke anvendes til menneskeføde eller foder.

Ved håndtering af det bejdsede korn bær beskyttelseshandsker.

Beholderen/emballagen må ikke anvendes til brødkorn, andre levnedsmidler og

foderstoffer.

Det bejdsede korn er giftigt for fugle og pattedyr. Ved såning skal det bejdsede

korn dækkes med jord. Ikke dækkede korn skal opsamles.

Dispensation til såning gælder frem til 31. oktober 2015.

Ovenstående indrammede angivelse skal være tydeligt anført på en etikette eller

bindemærke, der straks skal fastgøres på beholderen/emballagen på en sådan

måde, at etiketten eller bindemærket normalt vil blive siddende indtil indholdet er

brugt.

Opbevares utilgængeligt for børn (P102).

Må ikke opbevares sammen med fødevarer, drikkevarer og foderstoffer.

Førstehjælp

Hvis der er brug for lægehjælp, medbring da beholderen eller etiketten (P101).

Indånding: Bring personen i frisk luft.

Hud:

VED KONTAKT MED HUDEN: Vask med rigeligt vand (P302+P352).

Ved hudirritation eller udslæt: Søge lægehjælp (P333+P313).

Alt tilsmudset tøj tages af og vaskes inden genanvendelse (P362+P364).

Øjne:

VED KONTAKT MED ØJNENE: Skyl forsigtigt med vand i flere minutter.

Fjern eventuelle kontaktlinser, hvis dette kan gøres let. Fortsæt skylning

(P305+P351+P338).

Indtagelse: Fremkald ikke opkastning. Søg læge.

Brugsanvisning

Deter FS 250 er et bejdsemiddel til bejdsning af vinterhvede og vinterbyg imod angreb

af lus, der virker som vektor for overførsel af virus.

Det bejdsede korn må kun sås i risikoområder for virussygdommen havrerødsot, og

hvis der sås tidligt.

Der er ingen effekt på spireskadende svampe, og det anbefales derfor at der foretages

en bejdsning sammen med Redigo Pro FS 170.

Det er derfor nødvendigt at der anvendes bejdseanlæg, der har 3 pumpeanlæg, således

at Deter FS 250, Redigo Pro FS 170 samt vand kan tilsættes af separate pumper under

bejdsearbejdet.

For at sikre at der ikke dannes støv under bejdsearbejdet, skal der tilsættes Intego til

vandet ud fra blandingsforskriften.

Dosering

100 ml Deter FS 250 pr. 100 kg udsæd

Tilsætning af vand

For at sikre en tilstrækkelig dækning af kernen med bejdsemiddel, er det nødvendigt

at Deter FS 250 anvendes ved tilsætning af vand. Endelig vandmængde skal tilpasses

det enkelte bejdseanlæg, men som udgangspunkt kan der tilsættes 50-200 ml vand/

hkg korn således at den totale væskemængde (Deter, Redigo Pro + vand), kommer op

på 200 - 350 ml/hkg.

Bejdseanlæg

Bejdsning skal foregå i et egnet bejdseanlæg, der kan udføre en kvalitetsbejdsning.

Anlægget bør være i god stand og kalibreret for at udføre tilfredsstillende bejdsning med

Deter FS 250. Sugeslangen fra pumpen skal placeres direkte i originalemballagen, for

at minimere kontakt med midlet.

Rengøring

Før og efter bejdsningen bør maskiner, pumper m.m. rengøres grundigt. Deter FS 250

er vandbaseret. Det betyder, at rengøring kan foretages med vand i maskiner, hvor der

udelukkende anvendes Deter FS 250. Eventuelt vaskevand skal bortskaffes som kemisk

affald.

Udsåning og spild ved udsåning

Det bejdsede korn er giftigt for fugle og pattedyr. Der anvendes passende radsånings-

udstyr der sikrer en god nedfældning i jorden, minimalt spild under anvendelsen og

minimal frigivelse af støv. Behandlet udsæd bør udsås samme år, det er bejdset.

For at sikre at fugle og pattedyr ikke kommer i kontakt med det bejdsede korn, skal der

udvises ekstra omhyggelighed ved udsåning især vendinger på foragre. Eventuelt spild

skal enten straks opsamles, eller området harves og tromles for at minimere udsæd på

overfladen.

Begrænsninger

Såsæd med lav spireevne og/eller lav spirehastighed og/eller vandindhold over 16%,

eller udsæd med afskallede eller sprukne kerner bør ikke bejdses og anvendes som

udsæd.

Opbevaring

Opbevares frostfrit.

Opbrudt emballage skal lukkes omhyggeligt efter brug.

Rester og tom emballage

Indholdet/beholderen bortskaffes i overensstemmelse med kommunale regler for af-

faldshåndtering (P501):

Rester skal afleveres til den kommunale affaldsordning for farligt affald.

Tomme beholdere kan bortskaffes med dagrenovationen.

Emballagen må ikke genbruges.

Resistensdannelse

Det kan ikke udelukkes, at skadedyr (f.eks. bladlus) udvikler resistens overfor Deter FS

250. Bayer CropScience hæfter ikke for tab, der kan opstå på denne måde.

Gentagen anvendelse af samme middel eller midler med samme virkemekanisme kan

resultere i dannelse af resistens.

For at undgå dette, anbefales det med jævne mellemrum at anvende midler med anden

virkemekanisme, eksempelvis som sprøjtning.

Deter FS 250 indeholder clothianidin der tilhører gruppen neonicotinoider (IRAC gruppe

4A). Der er ikke i Danmark konstateret resistens hos bladlus imod neonicotinoider på

friland.

7.2015

Insektmiddel nr. 18-592

Omfattet af Miljøstyrelsens dispensation gældende fra juli 2015.

Analyse

Clothianidin ………………… 250 g/l (22,10% w/w)

Netto 200 liter

Flydende

Midlet er et suspensionskoncentrat til bejdsning

Fabr.nr.: se påklæbede seddel

Produktet er ved korrekt opbevaring og uåbnet emballage holdbart i mindst 2 år efter

produktionsdatoen. Produktionsdato påtrykt emballagen.

® is a registered trademark of the Bayer Group

Insektmiddel

Må kun anvendes til indendørs bejdsning af vinter-

hvede og vinterbyg i lukkede industrielle anlæg.

Bayer A/S

Bayer CropScience

Arne Jacobsens Allé 13

DK-2300 København S

Tlf. 4523 5000

www.cropscience.bayer.dk

200 liter

FS 250

21-07-2015

2-11-2018

Brin de Folie recalls Wind-up Racoon Toys

Brin de Folie recalls Wind-up Racoon Toys

Health Canada's sampling and evaluation program has determined that the affected products do not meet the Canadian safety requirements for toys. The tail can detach from the toy, posing a choking hazard to young children.

Health Canada

24-10-2018

FDA permits marketing of a diagnostic test to aid in the determination of menopausal status

FDA permits marketing of a diagnostic test to aid in the determination of menopausal status

FDA permits marketing of a diagnostic test to aid in the determination of menopausal status

FDA - U.S. Food and Drug Administration

18-10-2018

CTG recalls Friction Powered School Bus

CTG recalls Friction Powered School Bus

Health Canada's sampling and evaluation program has determined that the school bus toy does not meet Canadian safety requirements for toys. Specifically, the school bus released small parts during testing, which are a choking hazard for young children.

Health Canada

16-10-2018

Assessment of low pathogenic avian influenza virus transmission via raw poultry meat and raw table eggs

Assessment of low pathogenic avian influenza virus transmission via raw poultry meat and raw table eggs

Published on: Mon, 15 Oct 2018 00:00:00 +0200 A rapid qualitative assessment has been done by performing a theoretical analysis on the transmission of low pathogenic avian influenza (LPAI) via fresh meat from poultry reared or kept in captivity for the production of meat (raw poultry meat) or raw table eggs. A predetermined transmission pathway followed a number of steps from a commercial or non‐commercial poultry establishment within the EU exposed to LPAI virus (LPAIV) to the onward virus transmission...

Europe - EFSA - European Food Safety Authority Publications

16-10-2018

Evaluation of confirmatory data following the Article 12 MRL review for teflubenzuron

Evaluation of confirmatory data following the Article 12 MRL review for teflubenzuron

Published on: Mon, 15 Oct 2018 00:00:00 +0200 The applicant BASF Agro BV submitted a request to the competent national authority in United Kingdom to evaluate the confirmatory data that were identified for teflubenzuron in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. To address the data gaps, a new metabolism study on leafy crops, a study investigating the nature of residues under standard hydrolytic conditions and a validated ...

Europe - EFSA - European Food Safety Authority Publications

15-10-2018

Toy Land Company recalls Boom Boom ChemsSlime andPutty

Toy Land Company recalls Boom Boom ChemsSlime andPutty

Health Canada has determined that the slime and putty products do not meet the Canadian toy safety requirements related to boric acid content.

Health Canada

15-10-2018

Dollar Novelty (Karapelle Inc) recalls Barrel-O-Slime Toy

Dollar Novelty (Karapelle Inc) recalls Barrel-O-Slime Toy

Health Canada's sampling and evaluation program has determined the Barrel-O-Slime toy does not meet the Canadian toy safety requirements related to boric acid content.

Health Canada

11-10-2018

FDA approves new DNA-based test to determine blood compatibility

FDA approves new DNA-based test to determine blood compatibility

FDA approves new DNA-based test to determine blood compatibility.Test is first of this type approved to report genotypes as final results

FDA - U.S. Food and Drug Administration

2-10-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency actions to further deter ‘gaming’ of the generic drug approval process by the use of citizen petitions

Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency actions to further deter ‘gaming’ of the generic drug approval process by the use of citizen petitions

FDA issues revised guidance to allow for a more efficient approach to 505(q) petitions and focus more resources on scientific reviews.

FDA - U.S. Food and Drug Administration

21-9-2018

Scientific guideline:  Guideline on determination of withdrawal periods for edible tissues - Revision 1, adopted

Scientific guideline: Guideline on determination of withdrawal periods for edible tissues - Revision 1, adopted

This document provides a standard approach to be used across the European Union in the analysis of residue depletion data for the purpose of establishing withdrawal periods for edible tissues. Emphasis has been put on a statistical approach. As the method of first choice, a linear regression technique is recommended. A computerised version of the method described is available: Updated application software: withdrawal time calculation for tissues. Read together with the explanatory note on updated applica...

Europe - EFSA - European Food Safety Authority EFSA Journal

21-9-2018

Modification of the existing maximum residue level for clothianidin in potatoes

Modification of the existing maximum residue level for clothianidin in potatoes

Published on: Thu, 20 Sep 2018 00:00:00 +0200 In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Bayer CropScience AG submitted a request to the competent national authority in Germany to modify the existing maximum residue level (MRL) for the active substance clothianidin to accommodate the use on potatoes imported from Canada. The data submitted in support of the request were found to be sufficient to derive a MRL proposal. Adequate analytical methods for enforcement are availa...

Europe - EFSA - European Food Safety Authority Publications

20-9-2018

Siu & Sons Int'l Trading recalls Color Fantastik Assorted Rubber Animal Toys

Siu & Sons Int'l Trading recalls Color Fantastik Assorted Rubber Animal Toys

Health Canada's sampling and evaluation program has determined that the rubber animals do not meet the Canadian safety requirements for toys. The squeakers inside the rubber animals can be easily removed; these small parts pose a choking hazard to young children.

Health Canada

19-9-2018

Exclusive Brands and iSweet recall Kidsmania Bubble Dozer

Exclusive Brands and iSweet recall Kidsmania Bubble Dozer

Health Canada's sampling and evaluation program has determined that these products do not meet the Canadian safety requirements for toys.Small parts can break off the toys, posing a choking hazard to young children.

Health Canada

18-9-2018

Les Distributions Orca Lite Inc. recalls FLEXI LIGHT multi-purpose utility lighters

Les Distributions Orca Lite Inc. recalls FLEXI LIGHT multi-purpose utility lighters

Health Canada's sampling and evaluation program has determined that these lighters do not meet the Lighters Regulations in Canada and may pose a fire or burn hazard. Specifically, the child-resistant mechanism may not work properly.

Health Canada

12-9-2018

Application of data science in risk assessment and early warning

Application of data science in risk assessment and early warning

Published on: Mon, 27 Aug 2018 00:00:00 +0200 The currently applied approaches, procedures and tools used for the identification of emerging risks vary greatly among Member States of the EU. EFSA established a structured approach for emerging risk identification that mainly consists of systematically searching, collecting, collating and analysing information and data. In addition, EFSA concluded that new methodologies and tools are needed to facilitate efficient and transparent sharing of data, knowledg...

Europe - EFSA - European Food Safety Authority Publications

11-9-2018

Update of the Xylella spp. host plant database

Update of the Xylella spp. host plant database

Published on: Mon, 10 Sep 2018 00:00:00 +0200 Following a request from the European Commission, EFSA periodically updates the database on the host plants of Xylella spp. While previous editions of the database (2015 and 2016) dealt with the species Xylella fastidiosa only, this database version addresses the whole genus Xylella, including therefore both species X. fastidiosa and Xylella taiwanensis. The database now includes information on host plants of Xylella spp. retrieved from scientific literature...

Europe - EFSA - European Food Safety Authority Publications

10-9-2018

Health Canada updates Canadians on estimates of health risks for recalled valsartan drugs containing NDMA

Health Canada updates Canadians on estimates of health risks for recalled valsartan drugs containing NDMA

OTTAWA –Health Canada is sharing the results of its review of potential long-term health effects involving valsartan drugs that were found to contain the impurity N-nitrosodimethylamine (NDMA). Health Canada scientists have assessed the available data to determine the potential increased risk of developing cancer, to help put the risk into context for Canadians.

Health Canada

10-9-2018

Kangaroo Manufacturing Inc. recalls Kangaroo's Super Cool Slime

Kangaroo Manufacturing Inc. recalls Kangaroo's Super Cool Slime

Health Canada's sampling and evaluation program has determined the Super Cool Slime products donot meet the Canadian toy safety requirements related to boric acid content.

Health Canada

30-8-2018

Great Canadian Dollar Store recalls Lobster Plush Toys

Great Canadian Dollar Store recalls Lobster Plush Toys

Health Canada's sampling and evaluation program has determined that these plush toys do not meet the Canadian safety requirements for toys. The hard plastic eyes on these plush toys can detach, posing a choking hazard to young children.

Health Canada

29-8-2018

Explanatory note on the determination of newly expressed protein levels in the context of genetically modified plant applications for EU market authorisation

Explanatory note on the determination of newly expressed protein levels in the context of genetically modified plant applications for EU market authorisation

Published on: Mon, 20 Aug 2018 00:00:00 +0200 Genetically modified organisms are subject to a risk assessment and regulatory approval before entering the European market. According to legislation (Directive 2001/18/EC, Regulation (EC) No 1829/2003 and Regulation (EU) No 503/2013) and the EFSA guidance documents on the risk assessment of food and feed from genetically modified (GM) plants and on the environmental risk assessment of GM plants, applicants need to perform a molecular characterisation of any...

Europe - EFSA - European Food Safety Authority Publications

29-8-2018

Safety assessment of the process ‘General Plastic’, based on Starlinger Decon technology, used to recycle post‐consumer PET into food contact materials

Safety assessment of the process ‘General Plastic’, based on Starlinger Decon technology, used to recycle post‐consumer PET into food contact materials

Published on: Fri, 10 Aug 2018 00:00:00 +0200 This scientific opinion of the EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF Panel) deals with the safety evaluation of the recycling process General Plastic (EU register No RECYC153), which is based on the Starlinger Decon technology. The decontamination efficiency of the process was demonstrated by a challenge test. The input of this process is hot caustic washed and dried poly(ethylene terephthalate) (PET) flakes orig...

Europe - EFSA - European Food Safety Authority Publications

24-8-2018

Imagine recalls Buckyballs magnet sets

Imagine recalls Buckyballs magnet sets

Health Canada has determined that these magnet sets are a danger to human health and safety because they contain small powerful magnets which can be easily swallowed or inhaled by children. Unlike other small objects that would be more likely to pass normally through the digestive system if swallowed, when more than one small powerful magnet is swallowed, the magnets can attract one another while travelling through the digestive system. The magnets can then pinch together and create a blockage and slowly...

Health Canada

14-8-2018

Genius Premium Craft Boxes recalls Do-It-Yourself Slime Kits

Genius Premium Craft Boxes recalls Do-It-Yourself Slime Kits

Health Canada’s sampling and evaluation program has determined the Do-It-Yourself Slime Kits do not meet the Canadian toy safety requirements related to boric acid content.

Health Canada

3-8-2018

Scientific guideline:  Cholic acid capsules 50 mg and 250 mg product-specific bioequivalence guidance, adopted

Scientific guideline: Cholic acid capsules 50 mg and 250 mg product-specific bioequivalence guidance, adopted

Cholic acid capsules 50 mg and 250 mg product-specific bioequivalence guidance

Europe - EFSA - European Food Safety Authority EFSA Journal

31-7-2018

Public Notification: Black Rhino 25000 contains hidden drug ingredient

Public Notification: Black Rhino 25000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Black Rhino 25000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

31-7-2018

Public Notification: Krazzy Rhino 25000 contains hidden drug ingredient

Public Notification: Krazzy Rhino 25000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Krazzy Rhino 25000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

31-7-2018

Public Notification: Gold Rhino 25000 contains hidden drug ingredient

Public Notification: Gold Rhino 25000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Gold Rhino 25000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

31-7-2018

Public Notification: Platinum Rhino 25000 contains hidden drug ingredient

Public Notification: Platinum Rhino 25000 contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use Platinum Rhino 25000, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

20-7-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to encourage the development of and broaden access to generic versions of opioid analgesics that are formulated to deter abuse

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to encourage the development of and broaden access to generic versions of opioid analgesics that are formulated to deter abuse

FDA posted a new batch of 43 product-specific guidances related to the development of generic drug products that includes three revised product-specific guidances for ADF opioid products. These guidances recommend specific in vivo studies and in vitro study considerations for abuse deterrence evaluations.

FDA - U.S. Food and Drug Administration

20-7-2018

J2Labz recalls Sugar Shack Vaping Liquid

J2Labz recalls Sugar Shack Vaping Liquid

Health Canada's sampling and evaluation program has determined that these vaping products do not meet the packaging and labelling requirements of the Consumer Chemicals and Containers Regulations, 2001 under the Canada Consumer Product Safety Act.

Health Canada

10-7-2018

Preventieve HIV-remmers (PrEP) worden verstrekt voor een periode van vijf jaar

Preventieve HIV-remmers (PrEP) worden verstrekt voor een periode van vijf jaar

PrEP wordt binnen een onderzoekssetting voor een periode van vijf jaar verstrekt aan de hoogrisicogroep van mannen die seks hebben met mannen (MSM). Dat heeft minister Bruno Bruins (Medische Zorg) vandaag bekend gemaakt. Op basis van schattingen van het RIVM zullen ongeveer 6500 mannen hiervan gebruik gaan maken en kunnen hiermee  250 hiv-infecties per jaar worden voorkomen. Voor gebruikers gaat een eigen bijdrage gelden van maximaal 25%, dat komt overeen met ongeveer 12 euro per maand. Ook wordt hen gev...

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

6-7-2018

Expanded Recall: Peg Perego Canada Inc. recalls Various Book Strollers

Expanded Recall: Peg Perego Canada Inc. recalls Various Book Strollers

Health Canada's sampling and evaluation program has determined that these strollers do not meet the Carriages and Strollers Regulations in Canada. Specifically, the strollers do not meet the latching system requirements for folding strollers as they do not have a safety device independent of the latching device to prevent folding.

Health Canada

27-6-2018

Canadian Tire Corporation, Limited recalls MASTER Chef BBQ Igniter lighters

Canadian Tire Corporation, Limited recalls MASTER Chef BBQ Igniter lighters

Health Canada’s sampling and evaluation program has determined that these lighters do not meet the Lighters Regulations in Canada and may pose a fire or burn hazard.Specifically the lighters:

Health Canada

26-6-2018

Home Hardware Stores Ltd. recalls Home Flexible Multi-Purpose Lighter

Home Hardware Stores Ltd. recalls Home Flexible Multi-Purpose Lighter

Health Canada's sampling and evaluation program has determined that these lighters do not meet the Lighters Regulations in Canada and may pose a fire or burn hazard. Specifically the lighters:

Health Canada

20-6-2018

Bumbleride Inc recalls Bumbleride Speed 3-wheel jogging stroller

Bumbleride Inc recalls Bumbleride Speed 3-wheel jogging stroller

Health Canada's sampling and evaluation program has determined that this jogging stroller does not meet the sharp edge requirements of the Carriages and Strollers Regulations in Canada. The metal edge of the back hinge located on the right side of the jogging stroller can be sharp, posing a potential risk of cut or laceration.

Health Canada

1-6-2018

Château Manis Électroniques Inc. recalls Chateau brand gas lighters

Château Manis Électroniques Inc. recalls Chateau brand gas lighters

Health Canada's sampling and evaluation program has determined that these lighters do not meet the Lighters Regulations in Canada and may pose a fire or burn hazard. Specifically the lighters:

Health Canada

29-5-2018

Expanded Recall: Stroller Boutique recalls Anex Sport stroller

Expanded Recall: Stroller Boutique recalls Anex Sport stroller

Health Canada’s sampling and evaluation program has determined these strollers do not meet the Carriages and Strollers Regulations in Canada. Specifically, the strollers contain barium in excess of allowable limits. Additionally, these strollers do not meet Health Canada's stability requirements. These strollers may tip-over while in use, posing a fall hazard.

Health Canada

23-5-2018

Ten Thousand Villages Canada recalls Choo-Choo Train & Blocks Set

Ten Thousand Villages Canada recalls Choo-Choo Train & Blocks Set

Health Canada's sampling and evaluation program has determined that the recalled toy does not meet the Canadian safety requirements for toys. The numbered blocks are small parts and the toy may further break apart exposing more small parts, posing a choking hazard for young children.

Health Canada

4-5-2018

Badger Botanicals Recalls Red Suma, Green Suma, Green Hulu 2, And Red Hulu 2 Kratom Supplements Because Of Possible Salmonella Health Risk

Badger Botanicals Recalls Red Suma, Green Suma, Green Hulu 2, And Red Hulu 2 Kratom Supplements Because Of Possible Salmonella Health Risk

Badger Botanicals, LLC of Springville, Utah is recalling Green Suma, Red Suma, Green Hulu 2, and Red Hulu 2 kratom dietary supplements sold directly to consumers via the company website from January 1st, 2018 to April l 12th, 2018 in pouches of 250g, because it has the potential to be contaminated with Salmonella.

FDA - U.S. Food and Drug Administration

8-6-2015

Many addictive drugs lacked statutory packaging seal

Many addictive drugs lacked statutory packaging seal

The Danish Health and Medicines Authority’s laboratory has made a thorough investigation and found that 70 of 229 addictive drugs in the Danish market lacked the statutory packaging seal on the outer packaging. The seal makes it easy to determine whether the package has been broken before it reaches the end user. The aim is to prevent abuse.

Danish Medicines Agency

15-1-2014

Revocation of wholesale distribution and manufacturing authorisations granted to Singad Pharma ApS

Revocation of wholesale distribution and manufacturing authorisations granted to Singad Pharma ApS

On 20 December 2013 and on 10 January 2014, the Danish Health and Medicines Authority decided to revoke the section 39 authorisations for wholesale distribution and manufacturing of medicinal products with the authorisation IDs 25081 and 25082 granted to Singad Pharma ApS (company number 255894).

Danish Medicines Agency

30-10-2018

EU/3/14/1250 (Akcea Therapeutics UK Ltd)

EU/3/14/1250 (Akcea Therapeutics UK Ltd)

EU/3/14/1250 (Active substance: Phosphorothioate oligonucleotide targeted to transthyretin) - Transfer of orphan designation - Commission Decision (2018)7282 of Tue, 30 Oct 2018 European Medicines Agency (EMA) procedure number: EMA/OD/098/13/T/01

Europe -DG Health and Food Safety

29-10-2018

Replagal (Shire Human Genetic Therapies AB)

Replagal (Shire Human Genetic Therapies AB)

Replagal (Active substance: Agalsidase alfa) - Centralised - Yearly update - Commission Decision (2018)7250 of Mon, 29 Oct 2018

Europe -DG Health and Food Safety

21-10-2018

Fortunately, while women were underrepresented, the trials were large enough w/adequate #’s of women to determine safety and effectiveness. #FDA continues taking steps to encourage greater inclusion of women in trials, including OWH’s Diverse Women in Cli

Fortunately, while women were underrepresented, the trials were large enough w/adequate #’s of women to determine safety and effectiveness. #FDA continues taking steps to encourage greater inclusion of women in trials, including OWH’s Diverse Women in Cli

Fortunately, while women were underrepresented, the trials were large enough w/adequate #’s of women to determine safety and effectiveness. #FDA continues taking steps to encourage greater inclusion of women in trials, including OWH’s Diverse Women in Clinical Trials Initiative. pic.twitter.com/20d9Sg2vqn

FDA - U.S. Food and Drug Administration

24-9-2018

aimed at determining how best to assess safety and effectiveness of digital health technologies without inhibiting patient access. Click on the link to register:  https://bit.ly/2pxdczF 

aimed at determining how best to assess safety and effectiveness of digital health technologies without inhibiting patient access. Click on the link to register: https://bit.ly/2pxdczF 

aimed at determining how best to assess safety and effectiveness of digital health technologies without inhibiting patient access. Click on the link to register: https://bit.ly/2pxdczF 

FDA - U.S. Food and Drug Administration

5-9-2018

Patients may not have access to an #FDA approved or cleared device in the absence of adequate coverage. That’s why we’re expanding our work with private payors to help narrow the time it takes for payors to make a coverage determination on new medical dev

Patients may not have access to an #FDA approved or cleared device in the absence of adequate coverage. That’s why we’re expanding our work with private payors to help narrow the time it takes for payors to make a coverage determination on new medical dev

Patients may not have access to an #FDA approved or cleared device in the absence of adequate coverage. That’s why we’re expanding our work with private payors to help narrow the time it takes for payors to make a coverage determination on new medical devices

FDA - U.S. Food and Drug Administration

5-9-2018

#FDA announces draft guidance: Consideration of Uncertainty in Making Benefit-Risk Determinations in #MedicalDevice Premarket Approvals. The document is now open for comment for 90 days. Click the link to review the draft guidance and provide comments:  h

#FDA announces draft guidance: Consideration of Uncertainty in Making Benefit-Risk Determinations in #MedicalDevice Premarket Approvals. The document is now open for comment for 90 days. Click the link to review the draft guidance and provide comments: h

#FDA announces draft guidance: Consideration of Uncertainty in Making Benefit-Risk Determinations in #MedicalDevice Premarket Approvals. The document is now open for comment for 90 days. Click the link to review the draft guidance and provide comments: https://go.usa.gov/xPcpT  pic.twitter.com/hAuLWaIYiK

FDA - U.S. Food and Drug Administration

22-7-2018

Some devices come to market after #FDA determines that they're substantially equivalent to another legally marketed device called the predicate – this is the 510(k) pathway typically used for moderate risk devices.

Some devices come to market after #FDA determines that they're substantially equivalent to another legally marketed device called the predicate – this is the 510(k) pathway typically used for moderate risk devices.

Some devices come to market after #FDA determines that they're substantially equivalent to another legally marketed device called the predicate – this is the 510(k) pathway typically used for moderate risk devices.

FDA - U.S. Food and Drug Administration

3-7-2018

Samsca (Otsuka Pharmaceutical Europe Ltd)

Samsca (Otsuka Pharmaceutical Europe Ltd)

Samsca (Active substance: tolvaptan) - Centralised - 2-Monthly update - Commission Decision (2018) 4250 of Tue, 03 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/980/II/31

Europe -DG Health and Food Safety

2-7-2018

Therapeutic Goods (Human Cells, Tissues and Organs) Determination 2018: Guideline

Therapeutic Goods (Human Cells, Tissues and Organs) Determination 2018: Guideline

Outlines the circumstances in which items included in the Therapeutic Goods (Human Cells, Tissues and Organs) Determination 2018 would not be within the TGA regulatory framework

Therapeutic Goods Administration - Australia

18-6-2018

Updates to the Permissible Ingredients Determination for listed medicines

Updates to the Permissible Ingredients Determination for listed medicines

The Therapeutic Goods (Permissible Ingredients) Determination No. 2 of 2018 has been published on the Federal Register of Legislation

Therapeutic Goods Administration - Australia

6-6-2018

Stocrin (Merck Sharp and Dohme B.V.)

Stocrin (Merck Sharp and Dohme B.V.)

Stocrin (Active substance: efavirenz) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3689 of Wed, 06 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/250/T/113

Europe -DG Health and Food Safety

23-4-2018

Mylotarg (Pfizer Limited)

Mylotarg (Pfizer Limited)

Mylotarg (Active substance: gemtuzumab ozogamicin) - New authorisation - Commission Decision (2018)2504 of Mon, 23 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4204

Europe -DG Health and Food Safety